化工社化工社 化学情報印刷レポート · 研究参考用
(R)-1-(2-メトキシフェニル)エチルアミン
(R)-1-(2-メトキシフェニル)エチルアミン · 2-Methoxy-a-Methyl- · (R)-2-Methoxy-α-methylbenzylamine · (R)-1-(2-METHOXYPHENYL)ETHYLAMINE · (R)-1-(2-METHOXYPHENYL)ETHANAMINE · (R)-o-Methoxy-alpha-phenethylamine · (R)-1-(2-methoxyphenyl)ethan-1-amine · (R)-(+)-2-METHOXY A-METHYLBENZYLAMINE

識別子と物理属性
| CAS No. | 68285-23-4 |
|---|---|
| 分子式 | C9H13NO |
| 平均分子量 | 151.21 g/mol |
| 単同位体質量 | 151.09971404 g/mol |
| SMILES | COc1ccccc1[C@@H](C)N |
| InChIKey | VENQOHAPVLVQKV-SSDOTTSWSA-N |
| PubChem CID | 853083 |
| EC No. | 662-799-8 |
| DTXSID | DTXSID90357393 |
| 現地名 | (R)-1-(2-メトキシフェニル)エチルアミン |
化学・物理的性質
| XLogP | 1.2 |
|---|---|
| 極性表面積 | 35.3 |
| 水素結合供与体数 | 1 |
| 水素結合受容体数 | 2 |
| 回転可能結合数 | 2 |
| 重原子数 | 11 |
| 形式電荷 | 0 |
| 複雑度 | 116 |
| 沸点 | 118°C/17mm |
| 密度 | 1.003±0.06 g/cm3(Predicted) |
| 引火点 | 118°C/17mm |
| 貯蔵条件 | under inert gas (nitrogen or Argon) at 2-8°C |
| 溶解度 | ジメチルスルホキシドに可溶。 |
| 外観・状態 | liquid |
| pKa(酸解離定数) | 9.13±0.10(Predicted) |
| InChI | 1S/C9H13NO/c1-7(10)8-5-3-4-6-9(8)11-2/h3-7H,10H2,1-2H3/t7-/m1/s1 |
| InChIKey | VENQOHAPVLVQKV-SSDOTTSWSA-N |
| SMILES | COc1ccccc1[C@@H](C)N |
安全性と法規制
| GHS 分類 | DangerH314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]P260, P261, P264, P271, P273, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P363, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 42 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| Hazard Classes and Categories | Skin Corr. 1B (100%) |
| 水環境危害等級(WGK) | WGK 3 |
| 輸送番号(UN) | 2735 |
| 危険文句(R) | 21/22-34-52/53-20 |
| 危険表示 | C |
| 安全措置(S) | 26-36/37/39-61-45 |
| 危険等級 | 8Acute Tox. 3 InhalationAquatic Chronic 3Skin Corr. 1B |
| 包装等級 | III |
| 貯蔵分類 | 6.1D - Non-combustible acute toxic Cat.3toxic hazardous materials or hazardous materials causing chronic effects |
用途
使用
The derivatives of the compound, are used as a potential ligand in developing radioiodinated antagonists for in vivo imaging of 5-HT1A receptors.